TYRA · Tyra Biosciences, Inc.

$26.05 +0.36 (+1.40%) At close · Aug 21

Market Cap

$1.55B

59.68M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-04	—
10-Q	2026-08-04	2026-06-30
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-06-02	2026-05-28
10-Q	2026-05-13	2026-03-31
8-K	2026-05-13	—
8-K	2026-04-17	2026-04-16
DEF 14A	2026-04-17	2026-05-28
8-K	2026-04-02	2026-04-01
8-K	2026-03-04	—
8-K	2026-03-02	—
10-K	2026-03-02	2025-12-31
8-K	2025-12-01	2025-11-25
10-Q	2025-11-05	2025-09-30
8-K	2025-11-05	—
8-K	2025-08-22	2025-08-21
10-Q	2025-08-14	2025-06-30
8-K	2025-08-14	—
8-K	2025-06-30	—
8-K	2025-05-29	—
10-Q	2025-05-08	2025-03-31
8-K	2025-05-08	—
DEF 14A	2025-04-18	2025-05-29
8-K	2025-03-27	—
10-K	2025-03-27	2024-12-31
8-K	2025-01-29	2025-01-28
8-K	2024-11-07	—
10-Q	2024-11-07	2024-09-30
8-K	2024-10-28	—
8-K	2024-10-25	2024-10-24
8-K	2024-10-18	—
10-Q	2024-08-07	2024-06-30
8-K	2024-08-07	—
8-K	2024-05-31	2024-05-29
10-Q	2024-05-09	2024-03-31
8-K	2024-05-09	—
8-K	2024-05-07	2024-05-04
DEF 14A	2024-04-18	2024-05-29
10-K	2024-03-19	2023-12-31
8-K	2024-03-19	—
8-K	2024-02-05	2024-02-01
8-K	2024-02-01	—
8-K	2023-12-22	—
10-Q	2023-11-07	2023-09-30
8-K	2023-11-07	—
8-K	2023-10-26	—
10-Q	2023-08-10	2023-06-30
8-K	2023-08-10	—
8-K	2023-06-02	2023-05-31
8-K	2023-05-04	—

Showing 1–50 of 70 filings

Key facts CIK 1863127 CUSIP 90240B106 13F (30d) 159 filings 157 filers Visit website Investor relations